BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28684326)

  • 1. Microfluidic technologies for anticancer drug studies.
    Valente KP; Khetani S; Kolahchi AR; Sanati-Nezhad A; Suleman A; Akbari M
    Drug Discov Today; 2017 Nov; 22(11):1654-1670. PubMed ID: 28684326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic culture models to study the hydrodynamics of tumor progression and therapeutic response.
    Buchanan C; Rylander MN
    Biotechnol Bioeng; 2013 Aug; 110(8):2063-72. PubMed ID: 23616255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Targeting of Tumor Cells in a Microfluidic Tumor Model with Multiple Cell Types.
    van de Crommert B; Palacio-Castañeda V; Verdurmen WPR
    Methods Mol Biol; 2024; 2804():237-251. PubMed ID: 38753152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successes and future outlook for microfluidics-based cardiovascular drug discovery.
    Skommer J; Wlodkowic D
    Expert Opin Drug Discov; 2015 Mar; 10(3):231-44. PubMed ID: 25672221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-on-a-chip for Drug Screening.
    Lee IC
    Curr Pharm Des; 2018; 24(45):5407-5418. PubMed ID: 30727877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
    Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
    ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of Microfluidic Spheroid Cultures for Biomedical Applications.
    Kwapiszewska K
    Methods Mol Biol; 2018; 1771():213-224. PubMed ID: 29633216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic-enabled self-organized tumor model for in vitro cytotoxicity assessment of doxorubicin.
    Yang Y; Liu S; Chen C; Huang H; Tao L; Qian Z; Li W
    Biomed Microdevices; 2020 Sep; 22(4):70. PubMed ID: 32960346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Microenvironment-on-Chip Platform for Assessing Drug Response in 3D Dynamic Culture.
    Aydin HB; Moon HR; Han B; Ozcelikkale A; Acar A
    Methods Mol Biol; 2024; 2764():265-278. PubMed ID: 38393600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreactors and Microfluidics for Osteochondral Interface Maturation.
    Canadas RF; Marques AP; Reis RL; Oliveira JM
    Adv Exp Med Biol; 2018; 1059():395-420. PubMed ID: 29736584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput 3D Tumor Culture in a Recyclable Microfluidic Platform.
    Liu W; Wang J
    Methods Mol Biol; 2017; 1612():293-301. PubMed ID: 28634952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs.
    Liu Y; Sakolish C; Chen Z; Phan DTT; Bender RHF; Hughes CCW; Rusyn I
    Toxicology; 2020 Dec; 445():152601. PubMed ID: 32980478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring tumor response to anticancer drugs using stable three-dimensional culture in a recyclable microfluidic platform.
    Liu W; Xu J; Li T; Zhao L; Ma C; Shen S; Wang J
    Anal Chem; 2015 Oct; 87(19):9752-60. PubMed ID: 26337449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Microfluidic Array to Study Drug Response in Breast Cancer.
    Virumbrales-Muñoz M; Livingston MK; Farooqui M; Skala MC; Beebe DJ; Ayuso JM
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31801265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viable cell culture in PDMS-based microfluidic devices.
    Tanyeri M; Tay S
    Methods Cell Biol; 2018; 148():3-33. PubMed ID: 30473072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ/body-on-a-chip based on microfluidic technology for drug discovery.
    Kimura H; Sakai Y; Fujii T
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):43-48. PubMed ID: 29175062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a Microfluidic Device for Culture and Drug Toxicity Testing of 3D Cells.
    Christoffersson J; Mandenius CF
    Methods Mol Biol; 2019; 1994():235-241. PubMed ID: 31124121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in microfluidic technologies for cell-to-cell interaction studies.
    Rothbauer M; Zirath H; Ertl P
    Lab Chip; 2018 Jan; 18(2):249-270. PubMed ID: 29143053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of anticancer drug cytotoxicity based on long-term HepG2 spheroid culture in a microfluidic system.
    Zuchowska A; Kwapiszewska K; Chudy M; Dybko A; Brzozka Z
    Electrophoresis; 2017 Apr; 38(8):1206-1216. PubMed ID: 28090668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.